APA (7th ed.) Citation

Yu, Y., Yao, P., Wang, Z., & Xie, W. Correction: MiR-137 promotes TLR4/NF-κB pathway activity through targeting KDM4 A, inhibits osteogenic diferentiation of human bone marrow mesenchymal stem cells and aggravates osteoporosis. BMC.

Chicago Style (17th ed.) Citation

Yu, Ying-feng, Pei-quan Yao, Zhi-kun Wang, and Wen-wei Xie. Correction: MiR-137 Promotes TLR4/NF-κB Pathway Activity Through Targeting KDM4 A, Inhibits Osteogenic Diferentiation of Human Bone Marrow Mesenchymal Stem Cells and Aggravates Osteoporosis. BMC.

MLA (9th ed.) Citation

Yu, Ying-feng, et al. Correction: MiR-137 Promotes TLR4/NF-κB Pathway Activity Through Targeting KDM4 A, Inhibits Osteogenic Diferentiation of Human Bone Marrow Mesenchymal Stem Cells and Aggravates Osteoporosis. BMC.